ArticleEuropean journal of clinical pharmacology2022

Response to: "Utility of endogenous 4β-hydroxycholesterol as a biomarker to assess cytochrome P 450 3A (CYP3A) activity: not quite ready for prime time".

Kine Eide Kvitne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.